BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8815574)

  • 1. Phenotyping and genotyping of coagulation factor V Leiden.
    Engel H; Zwang L; van Vliet HH; Michiels JJ; Stibbe J; Lindemans J
    Thromb Haemost; 1996 Feb; 75(2):267-9. PubMed ID: 8815574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
    Reuner KH; Litfin F; Patscheke H
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of factor V Leiden from a drop of blood by PCR-SSCP.
    Corral J; Iniesta JA; González-Conejero R; Vicente V
    Thromb Haemost; 1996 Nov; 76(5):735-7. PubMed ID: 8950782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detection of factor V Leiden (FVQ506) by non-radioactive single strand conformation polymorphism (SSCP).
    Arruda VR; von Zuben PM; Annichino-Bizzachi JM; Costa FF
    Sangre (Barc); 1996 Oct; 41(5):379-81. PubMed ID: 8986114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
    Bathelier C; Champenois T; Lucotte G
    Mol Cell Probes; 1998 Apr; 12(2):121-3. PubMed ID: 9633048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 9. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance.
    Kirschbaum NE; Foster PA
    Thromb Haemost; 1995 Sep; 74(3):874-8. PubMed ID: 8571314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
    Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple and reliable factor V genotyping by PNA-mediated PCR clamping.
    Behn M; Schuermann M
    Thromb Haemost; 1998 Apr; 79(4):773-7. PubMed ID: 9569191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
    Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P
    Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the factor V Leiden using SSCP.
    Margaglione M; D'Andrea G; Cappucci G; Grandone E; Giuliani N; Colaizzo D; Vecchione G; Di Minno G
    Thromb Haemost; 1996 Nov; 76(5):814-5. PubMed ID: 8950796
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
    Pereira J; Quiroga T; Goycoolea M; Muñoz B; Hidalgo P; Kaltwasser G; Mezzano D
    Rev Med Chil; 1996 Jun; 124(6):663-8. PubMed ID: 9041721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
    Zöller B; Holm J; Svensson P; Dahlbäck B
    Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid genotyping of factor V Leiden mutation using single-tube bidirectional allele-specific amplification and automated ultrathin-layer agarose gel electrophoresis.
    Sasvari-Szekely M; Gerstner A; Ronai Z; Staub M; Guttman A
    Electrophoresis; 2000 Mar; 21(4):816-21. PubMed ID: 10733227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific PCR amplification of factor V Leiden to identify patients at risk for thromboembolism.
    Blasczyk R; Wehling J; Ritter M; Neubauer A; Riess H
    Beitr Infusionsther Transfusionsmed; 1997; 34():236-41. PubMed ID: 9356679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple and rapid detection of factor V Leiden by allele-specific PCR amplification.
    Blasczyk R; Ritter M; Thiede C; Wehling J; Hintz G; Neubauer A; Riess H
    Thromb Haemost; 1996 May; 75(5):757-9. PubMed ID: 8725719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford.
    Zehnder JL; Hiraki DD; Jones CD; Gross N; Grumet FC
    Thromb Haemost; 1999 Sep; 82(3):1097-9. PubMed ID: 10494770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
    Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
    Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.